回盛生物：2025年半年度净利润约1.17亿元

Group 1 - The core viewpoint of the article highlights the significant growth in the financial performance of 回盛生物, with a reported revenue of approximately 822 million yuan for the first half of 2025, representing an increase of 88.45% year-on-year [1] - The net profit attributable to shareholders for the same period is approximately 117 million yuan, contrasting with a net loss of about 51.88 million yuan in the same period of 2024 [1] - The basic earnings per share for the first half of 2025 is reported at 0.6622 yuan, compared to a loss of 0.3127 yuan per share in the previous year [1] Group 2 - As of the report's release, the market capitalization of 回盛生物 stands at 5 billion yuan [1]